Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.

NCT03368989 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT03368989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03368989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Overall status
Completed
Start date
February 11, 2014
Completion date
February 7, 2017
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bony metastases from castrate refractory prostate cancer